临床查询*捷克
捷克
药物临床

临床查询*捷克

捷克共和国批准的临床试验的信息

标签:
爱站权重:PC 百度权重移动 百度移动权重

捷克共和国批准的临床试验的信息

Glossary of clinical trials terms:
Sponsor = An individual, company, institution or organization which takes responsibility for the initiation, management and/or financing of a clinical trial.
Study code / Protocol number = trial identifying number for sponsor
EudraCT number = EU trial identifying number
Subject = an individual who participates in a clinical trial, either as a recipient of the investigational product(s) or as a control; patient or healthy volunteer.
MEK = Ethics Committee for Multicentric Clinical Trials
Double-blind study = A clinical trial design in which neither the participating individuals (subjects) nor the study staff knows which participants are receiving the investigational drug and which are receiving a placebo or another therapy.
Randomized trial = A study in which participants/subjects are randomly (i.e. by chance) assigned to one of two or more treatment arms of a clinical trial.
Multicentric trial = a clinical trial conducted according to a single protocol but at more than one site and therefore, carried out by more than one investigator.
Placebo = an inactive pill, liquid, or powder that has no treatment value.

临床试验术语表:
申办方= 负责启动、管理和/或资助临床试验的个人、公司、机构或组织。
研究代码/方案编号= 申办
者的试验识别号EudraCT 号= EU 试验识别号
受试者= 参与临床试验的个人,作为研究产品的接受者或作为对照;患者或健康志愿者。
MEK = 多中心临床试验伦理委员会
双盲研究= 参与个人(受试者)和研究人员都不知道哪些参与者正在接受研究药物以及哪些正在接受安慰剂或其他疗法的临床试验设计。
随机试验= 参与者/受试者被随机(即偶然)分配到临床试验的两个或多个治疗组之一的研究。
多中心试验= 根据单一方案进行的临床试验,但在多个地点进行,因此由多个研究人员进行。
安慰剂= 没有治疗价值的非活性药丸、液体或粉末。

数据统计

相关导航

暂无评论

暂无评论...